| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 14,900 | $30 | $506.6K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 45,000 | $1 | $180K |
| J3262 | Injection, tocilizumab, 1 mg | 30,470 | $10 | $152.4K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 8,220 | $10 | $90.5K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 3,060 | $30 | $79.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 750 | $80 | $62.7K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 410 | $80 | $34.8K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 230 | $130 | $29.4K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 14,970 | $1 | $15K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 50 | $170 | $8.1K |